FDA NDC Directory · JSON-LD · Markdown

Paliperidone

NDC 69367-433 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerWestminster Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA218755
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsPALIPERIDONE (3 mg/1)
Marketing started20251209
Package count1

External sources

Source: openFDA. Public-domain (CC0).